A pan-cancer study focusing on comprehensive identification of mutated splice sites in matched whole-exome and transcriptome sequencing data from 8976 samples across 31 cancer types showed that TP53 was the most frequently altered gene in most cancers, including lung squamous cell carcinomas and lung adenocarcinomas [195]. The gene discussed is TP53; the disease is cancer.